Background
• The prevalence of chronic kidney disease (CKD) among individuals with type 2 diabetes mellitus (T2DM) is common.
• Literature reports that 34.5% to 42.3% of individuals with T2DM in the United States have CKD (due primarily to early stage CKD). [1] [2] [3] [4] [5] • Information is lacking on the recent temporal trends and prevalence within key demographic subgroups. 
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1085-P Objective
To estimate the prevalence of CKD stages in T2DM over time and within age, gender, and race subgroups.
Conclusions
• CKD, primarily early stage, is prevalent among individuals with T2DM, and more so in non-Hispanic blacks and MexicanAmericans, for whom aggressive early detection strategies along with evidence-based therapeutic interventions may be targeted in order to slow and/or prevent the progression of kidney function disease.
• The prevalence of CKD has remained fairly consistent over time, suggesting that current efforts to prevent CKD could be improved upon overall, and that the aforementioned populations may warrant even closer targeting for intervention.
• Patients not traditionally targeted for CKD screening, such as younger patients, also warrant attention. 
Limitations
• The cross-sectional nature of the data limited our ability to capture CKD progression within individuals.
• These results may only be generalized to non-institutionalized individuals.
• Older age, female gender, longer diabetes duration, higher systolic blood pressure were associated with declining kidney function.
• Hypertension, retinopathy, and cardiovascular diseases were common in the overall T2DM population. The prevalence of these comorbidities increased with CKD severity.
Methods
• This was a cross-sectional analysis of adults with T2DM utilizing data from the US National Health and Nutrition Examination Surveys -Participants with a diagnosis of T2DM were determined based on self-reported diabetes diagnosis or self-reported antidiabetic medication use -Participants were ≥ 18 years of age -Participants without a diagnosis of type 1 diabetes (defined as any diabetes diagnosis at age <30 years and receiving insulin treatment with no other ADM use) -Participants with information to determine estimated glomerular filtration rate (eGFR), including serum creatinine, age, gender and/or race -Participants who were not pregnant • CKD was categorized according to 2012 Kidney Disease Improving Global Outcomes (KDIGO) classification recommendations 6 (See Table 1 ) • eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).
• Prevalence, projected means, corrected variance estimates, and 95% confidence intervals were calculated and accounted for the complex sampling design.
• Age adjustment was applied to the CKD prevalence estimates in the overall T2DM population, based upon the age distribution of diagnosed diabetes (all types) in US adults from the 2012 U.S. Census 7 , and 2012 National Health Interview Survey 8 .
Results
• The overall age-adjusted CKD prevalence in T2DM adults from 2007-2012 was 38.3%.
• 29.7% of individuals with T2DM had mild to moderate CKD, and 8.6% had moderate to severe CKD.
• The prevalence of CKD in T2DM adults has remained fairly consistent over time.
CKD: chronic kidney disease; T2DM: type 2 diabetes mellitus
• CKD was more prevalent in non-Hispanic blacks and MexicanAmericans, compared with non-Hispanic whites.
• Nearly a quarter of Mexican-Americans with T2DM had Stage 1 CKD, accounting for more than half of CKD in this population. 
